Skip to Main Content

Author Details

Ganesh V Raj
University of Texas Southwestern Medical Center at Dallas
1994
184
56
PMIDPaper TitleJournal TitlePublished Year
37355762Critical role of antioxidant programs in enzalutamide-resistant prostate cancer.Oncogene2023
37766843Riluzole Suppresses Growth and Enhances Response to Endocrine Therapy in ER+ Breast Cancer.J Endocr Soc2023
34774676SABR for High-Risk Prostate Cancer: A Prospective Multilevel MRI-Based Dose Escalation Trial.Int J Radiat Oncol Biol Phys2022
35349486Targeting radioresistance and replication fork stability in prostate cancer.JCI Insight2022
35606411Enrichment of "Cribriform" morphologies (intraductal and cribriform adenocarcinoma) and genomic alterations in radiorecurrent prostate cancer.Mod Pathol2022
35654861Targeting LIPA independent of its lipase activity is a therapeutic strategy in solid tumors via induction of endoplasmic reticulum stress.Nat Cancer2022
35993980Alterations in BRCA2 as Determinants of Therapy Response in Prostate Cancer.Crit Rev Oncog2022
36062456Emerging hormonal agents for the treatment of prostate cancer.Expert Opin Emerg Drugs2022
35950923A First-in-Class Inhibitor of ER Coregulator PELP1 Targets ER+ Breast Cancer.Cancer Res2022
35881485Targeting ESR1 mutation-induced transcriptional addiction in breast cancer with BET inhibition.JCI Insight2022
35184376The central role of Sphingosine kinase 1 in the development of neuroendocrine prostate cancer (NEPC): A new targeted therapy of NEPC.Clin Transl Med2022
35265519Dose-Intensified Stereotactic Ablative Radiation for Localized Prostate Cancer.Front Oncol2022
34986150Poly-glutamine-dependent self-association as a potential mechanism for regulation of androgen receptor activity.PLoS One2022
33290775Jean Wilson and His Legacy, 50 Years and Counting.Urology2021
34884893Validation of SV2A-Targeted PET Imaging for Noninvasive Assessment of Neuroendocrine Differentiation in Prostate Cancer.Int J Mol Sci2021
34716410LIFR inhibition enhances the therapeutic efficacy of HDAC inhibitors in triple negative breast cancer.Commun Biol2021
33310350Synthesis and fluorine-18 radiolabeling of a phospholipid as a PET imaging agent for prostate cancer.Nucl Med Biol2021
33246846Safety, Efficacy, and Impact on Quality of Life of Palliative Robotic Cystectomy for Advanced Prostate Cancer.Clin Genitourin Cancer2021
33323969A detailed characterization of stepwise activation of the androgen receptor variant 7 in prostate cancer cells.Oncogene2021
33096336Dynamic differences between DNA damage repair responses in primary tumors and cell lines.Transl Oncol2021
33263560Overcoming oncogene addiction in breast and prostate cancers: a comparative mechanistic overview.Endocr Relat Cancer2021
32343676The landscape of RNA polymerase II-associated chromatin interactions in prostate cancer.J Clin Invest2020
31883965RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer.Cell Chem Biol2020
33127913Proline rich 11 (PRR11) overexpression amplifies PI3K signaling and promotes antiestrogen resistance in breast cancer.Nat Commun2020
32516092Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019.J Clin Oncol2020
32485222Mithramycin suppresses DNA damage repair via targeting androgen receptor in prostate cancer.Cancer Lett2020
30504123IFNγ-Induced IFIT5 Promotes Epithelial-to-Mesenchymal Transition in Prostate Cancer via miRNA Processing.Cancer Res2019
35582713Molecular mechanisms of enzalutamide resistance in prostate cancer.Cancer Drug Resist2019
31878959Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancers.Breast Cancer Res2019
31266829DNA-Dependent Protein Kinase Drives Prostate Cancer Progression through Transcriptional Regulation of the Wnt Signaling Pathway.Clin Cancer Res2019
31265359Dissecting Prognostic From Predictive Utility: Circulating AR-V7 Biomarker Testing for Advanced Prostate Cancer.J Clin Oncol2019
31486688An evaluation of fulvestrant for the treatment of metastatic breast cancer.Expert Opin Pharmacother2019
31370197A Structure-Activity Relationship Study of Bis-Benzamides as Inhibitors of Androgen Receptor-Coactivator Interaction.Molecules2019
31253147Discovery of a novel long noncoding RNA overlapping the LCK gene that regulates prostate cancer cell growth.Mol Cancer2019
31392132Biomarkers for platinum sensitivity in bladder cancer: are we there yet?Transl Androl Urol2019
31277776Magnetic Resonance Imaging-guided In-bore and Magnetic Resonance Imaging-transrectal Ultrasound Fusion Targeted Prostate Biopsies: An Adjusted Comparison of Clinically Significant Prostate Cancer Detection Rate.Eur Urol Oncol2019
31152147Activation of sphingosine kinase by lipopolysaccharide promotes prostate cancer cell invasion and metastasis via SphK1/S1PR4/matriptase.Oncogene2019
31142661EC359: A First-in-Class Small-Molecule Inhibitor for Targeting Oncogenic LIFR Signaling in Triple-Negative Breast Cancer.Mol Cancer Ther2019
30649971Investigational luteinizing hormone releasing hormone (LHRH) agonists and other hormonal agents in early stage clinical trials for prostate cancer.Expert Opin Investig Drugs2019
30446460Optimal sampling scheme in men with abnormal multiparametric MRI undergoing MRI-TRUS fusion prostate biopsy.Urol Oncol2019
28581200Natural history of 'second' biochemical failure after salvage radiation therapy for prostate cancer: a multi-institution study.BJU Int2018
30135575Alternative splicing in prostate cancer.Nat Rev Clin Oncol2018
30217566Targeting the turnover of oncoproteins as a new avenue for therapeutics development in castration-resistant prostate cancer.Cancer Lett2018
29991529Taxol Induces Brk-dependent Prosurvival Phenotypes in TNBC Cells through an AhR/GR/HIF-driven Signaling Axis.Mol Cancer Res2018
30117261A patient-derived explant (PDE) model of hormone-dependent cancer.Mol Oncol2018
30566875A Cellular Anatomy of the Normal Adult Human Prostate and Prostatic Urethra.Cell Rep2018
30467556Patient-derived Models Reveal Impact of the Tumor Microenvironment on Therapeutic Response.Eur Urol Oncol2018
30467127PARP-1 regulates DNA repair factor availability.EMBO Mol Med2018
29555663Targeting Bromodomain and Extra-Terminal (BET) Family Proteins in Castration-Resistant Prostate Cancer (CRPC).Clin Cancer Res2018
29439601A new class of agents for estrogen-receptor-positive breast cancer.Expert Rev Clin Pharmacol2018
  • 1 - 50 of 184

Recommended Authors

Brian D Robinson
Sandra and Edward Meyer Cancer Center
Career Start Year 2008
Number of shared co-authors 35
Jonathan L Wright
University of Washington Medical Center
Career Start Year 2005
Number of shared co-authors 18
Amirali Salmasi
University of California San Diego
Career Start Year 2005
Number of shared co-authors 4
Anne Y Warren
Cambridge University Hospitals National Health Service Foundation Trust
Career Start Year 2003
Number of shared co-authors 10
Jun Hyuk Hong
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 2002
Number of shared co-authors 2
Mathieu Latour
Centre Hospitalier de l'Universite de Montreal
Career Start Year 2001
Number of shared co-authors 9
Eleni Efstathiou
Houston Methodist Cancer Center
Career Start Year 2000
Number of shared co-authors 25
Jiaoti Huang
Duke University School of Medicine
Career Start Year 2000
Number of shared co-authors 26
Elisabeth I Heath
Karmanos Cancer Center, Wayne State University
Career Start Year 1999
Number of shared co-authors 36
Niall M Corcoran
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1997
Number of shared co-authors 13
Matthew B Rettig
David Geffen School of Medicine, University of California los angeles
Career Start Year 1995
Number of shared co-authors 40
Louis Lacombe
CHU de Quebec-Universite Laval
Career Start Year 1994
Number of shared co-authors 14
David I Quinn
USC Norris Comprehensive Cancer Center
Career Start Year 1993
Number of shared co-authors 14
Edwin M Posadas
Cedars-Sinai Medical Center
Career Start Year 1993
Number of shared co-authors 25
Choung-Soo Kim
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 1993
Number of shared co-authors 5
Raymond S Lance
Washington State University Elson S. Floyd College of Medicine
Career Start Year 1992
Number of shared co-authors 12
Marshall Scott Lucia
University of Colorado School of Medicine
Career Start Year 1991
Number of shared co-authors 8
Bruce Montgomery
Fred Hutchinson Cancer Center, University of Washington
Career Start Year 1990
Number of shared co-authors 38
Bernd Wullich
University Hospital Erlangen, Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)
Career Start Year 1989
Number of shared co-authors 0
Christopher M Hovens
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1989
Number of shared co-authors 8
Christopher P Evans
University of California Davis
Career Start Year 1988
Number of shared co-authors 40
Armen Aprikian
McGill University Health Centre, McGill University
Career Start Year 1987
Number of shared co-authors 7
Anders Bjartell
Skane University Hospital, Lund University
Career Start Year 1987
Number of shared co-authors 34
Bruce J Trock
Johns Hopkins University School of Medicine
Career Start Year 1984
Number of shared co-authors 30
David M Nanus
Sandra and Edward Meyer Cancer Center
Career Start Year 1983
Number of shared co-authors 31
Joseph L Chin
University of Western Ontario
Career Start Year 1982
Number of shared co-authors 6
David M Berman
Queen's University
Career Start Year 1982
Number of shared co-authors 12
Kenneth J Pienta
The Brady Urological Institute, Johns Hopkins University School of Medicine
Career Start Year 1981
Number of shared co-authors 43
Lawrence D True
University of Washington School of Medicine
Career Start Year 1980
Number of shared co-authors 38
Theodorus H van der Kwast
University Health Network, University of Toronto
Career Start Year 1974
Number of shared co-authors 28

Collaborators

Johann S de Bono
The Institute for Cancer Research
Co-authored papers 10
Kamel Khalili
Co-authored papers 10
Neil B Desai
University of Texas Southwestern Medical Center
Co-authored papers 8
Ralf Kittler
McDermott Center for Human Growth and Development.
Co-authored papers 7
Ram S Mani
UT Southwestern Medical Center
Co-authored papers 7
Stephen R Plymate
University of Washington
Co-authored papers 7
Adam Sharp
The Institute for Cancer Research
Co-authored papers 5
Alec Paschalis
The Institute for Cancer Research
Co-authored papers 5
Felix Y Feng
UCSF Medical Center-Mount Zion
Co-authored papers 5
Yunpeng Gao
University of Texas Southwestern Medical Center at Dallas
Co-authored papers 5
Luke A Selth
Adelaide Medical School, University of Adelaide
Co-authored papers 5
Wei Yuan
The Institute for Cancer Research
Co-authored papers 5
Suzanne Carreira
The Institute of Cancer Research
Co-authored papers 4
Rahul K Kollipara
McDermott Center for Human Growth and Development.
Co-authored papers 4
GuemHee Baek
UT Southwestern Medical Center
Co-authored papers 4
Arul M Chinnaiyan
University of Michigan Medical School.
Co-authored papers 4
Scott A Tomlins
Rogel Cancer Center, University of Michigan Medical School ann arbor
Co-authored papers 3
Jason S Carroll
Co-authored papers 3
Chao Xing
University of Texas Southwestern Medical Center
Co-authored papers 3
Shohreh Amini
Co-authored papers 3
Robert Jeffrey Karnes
Mayo Clinic
Co-authored papers 3
Robert B Den
Thomas Jefferson University Hospital
Co-authored papers 3
Douglas W Strand
University of Texas Southwestern Medical Center
Co-authored papers 3
Mohammed Kanchwala
The University of Texas Southwestern Medical Center
Co-authored papers 3
Susmita G Ramanand
UT Southwestern Medical Center
Co-authored papers 3
Dimple Chakravarty
Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Daniel E Spratt
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 2
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Co-authored papers 2
Gervaise H Henry
UT Southwestern Medical Center
Co-authored papers 2
Chul Ahn
University of Texas Southwestern Medical Center
Co-authored papers 2
Release 1.2